Obesity and psychotic disorders: Uncovering common mechanisms through metabolomics

Matej Orešič

Research output: Contribution to journalReview ArticleScientificpeer-review

13 Citations (Scopus)

Abstract

Primary obesity and psychotic disorders are similar with respect to the associated changes in energy balance and co-morbidities, including metabolic syndrome. Such similarities do not necessarily demonstrate causal links, but instead suggest that specific causes of and metabolic disturbances associated with obesity play a pathogenic role in the development of co-morbid disorders, potentially even before obesity develops. Metabolomics – the systematic study of metabolites, which are small molecules generated by the process of metabolism – has been important in elucidating the pathways underlying obesity-associated co-morbidities. This review covers how recent metabolomic studies have advanced biomarker discovery and the elucidation of mechanisms underlying obesity and its co-morbidities, with a specific focus on metabolic syndrome and psychotic disorders. The importance of identifying metabolic markers of disease-associated intermediate phenotypes – traits modulated but not encoded by the DNA sequence – is emphasized. Such markers would be applicable as diagnostic tools in a personalized healthcare setting and might also open up novel therapeutic avenues.
Original languageEnglish
Pages (from-to)614-620
JournalDisease models & mechanisms
Volume5
Issue number5
DOIs
Publication statusPublished - 2012
MoE publication typeA2 Review article in a scientific journal
EventThe obese species : Clinical and preclinical understanding of eating and energy balance disorders - Erice, Sicily, Italy
Duration: 21 Oct 201126 Oct 2011
http://theobesespecies.unipr.it/program (Workshop Program)

Fingerprint

Metabolomics
Psychotic Disorders
Obesity
DNA sequences
Biomarkers
Metabolites
Energy balance
Metabolism
Morbidity
Molecules
Metabolic Diseases
Delivery of Health Care
Phenotype

Cite this

@article{ca81b9a59b5d4c6fbbfd6eabd8dde207,
title = "Obesity and psychotic disorders: Uncovering common mechanisms through metabolomics",
abstract = "Primary obesity and psychotic disorders are similar with respect to the associated changes in energy balance and co-morbidities, including metabolic syndrome. Such similarities do not necessarily demonstrate causal links, but instead suggest that specific causes of and metabolic disturbances associated with obesity play a pathogenic role in the development of co-morbid disorders, potentially even before obesity develops. Metabolomics – the systematic study of metabolites, which are small molecules generated by the process of metabolism – has been important in elucidating the pathways underlying obesity-associated co-morbidities. This review covers how recent metabolomic studies have advanced biomarker discovery and the elucidation of mechanisms underlying obesity and its co-morbidities, with a specific focus on metabolic syndrome and psychotic disorders. The importance of identifying metabolic markers of disease-associated intermediate phenotypes – traits modulated but not encoded by the DNA sequence – is emphasized. Such markers would be applicable as diagnostic tools in a personalized healthcare setting and might also open up novel therapeutic avenues.",
author = "Matej Orešič",
year = "2012",
doi = "10.1242/dmm.009845",
language = "English",
volume = "5",
pages = "614--620",
journal = "Disease models & mechanisms",
issn = "1754-8403",
publisher = "Company of Biologists Ltd",
number = "5",

}

Obesity and psychotic disorders : Uncovering common mechanisms through metabolomics. / Orešič, Matej.

In: Disease models & mechanisms, Vol. 5, No. 5, 2012, p. 614-620.

Research output: Contribution to journalReview ArticleScientificpeer-review

TY - JOUR

T1 - Obesity and psychotic disorders

T2 - Uncovering common mechanisms through metabolomics

AU - Orešič, Matej

PY - 2012

Y1 - 2012

N2 - Primary obesity and psychotic disorders are similar with respect to the associated changes in energy balance and co-morbidities, including metabolic syndrome. Such similarities do not necessarily demonstrate causal links, but instead suggest that specific causes of and metabolic disturbances associated with obesity play a pathogenic role in the development of co-morbid disorders, potentially even before obesity develops. Metabolomics – the systematic study of metabolites, which are small molecules generated by the process of metabolism – has been important in elucidating the pathways underlying obesity-associated co-morbidities. This review covers how recent metabolomic studies have advanced biomarker discovery and the elucidation of mechanisms underlying obesity and its co-morbidities, with a specific focus on metabolic syndrome and psychotic disorders. The importance of identifying metabolic markers of disease-associated intermediate phenotypes – traits modulated but not encoded by the DNA sequence – is emphasized. Such markers would be applicable as diagnostic tools in a personalized healthcare setting and might also open up novel therapeutic avenues.

AB - Primary obesity and psychotic disorders are similar with respect to the associated changes in energy balance and co-morbidities, including metabolic syndrome. Such similarities do not necessarily demonstrate causal links, but instead suggest that specific causes of and metabolic disturbances associated with obesity play a pathogenic role in the development of co-morbid disorders, potentially even before obesity develops. Metabolomics – the systematic study of metabolites, which are small molecules generated by the process of metabolism – has been important in elucidating the pathways underlying obesity-associated co-morbidities. This review covers how recent metabolomic studies have advanced biomarker discovery and the elucidation of mechanisms underlying obesity and its co-morbidities, with a specific focus on metabolic syndrome and psychotic disorders. The importance of identifying metabolic markers of disease-associated intermediate phenotypes – traits modulated but not encoded by the DNA sequence – is emphasized. Such markers would be applicable as diagnostic tools in a personalized healthcare setting and might also open up novel therapeutic avenues.

U2 - 10.1242/dmm.009845

DO - 10.1242/dmm.009845

M3 - Review Article

VL - 5

SP - 614

EP - 620

JO - Disease models & mechanisms

JF - Disease models & mechanisms

SN - 1754-8403

IS - 5

ER -